Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders

Travel Medicine and Infectious Disease

Volumn 11, Issue 2, 2013, Pages 71-80

  Schneider, Cornelia ^a   Adamcova, Miriam ^b   Jick, Susan S ^c   Schlagenhauf, Patricia ^d   Miller, Mary K ^e   Rhein, Hans Georg ^b   Meier, Christoph R ^a,c,f  

^a UNIVERSITY OF BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e GENENTECH INC   (United States)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Atovaquone; Chloroquine; Mefloquine; Proguanil

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; MEFLOQUINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG EXPOSURE; EPILEPSY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PANIC; PERIPHERAL NEUROPATHY; PHOBIA; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; STRESS;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; CHEMOPREVENTION; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; MALARIA; MALE; MENTAL DISORDERS; MIDDLE AGED; ODDS RATIO; RISK; TRAVEL;

EID: 84876756748     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2013.02.008     Document Type: Article

References (22)

1. S. Toovey Mefloquine neurotoxicity: a literature review Travel Med Infect Dis 7 2009 2 6
2. C.R. Meier, K. Wilcock, and S.S. Jick The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials Drug Saf 27 2004 203 213 (Pubitemid 38315329)
3. P. Schlagenhauf, A. Tschopp, R. Johnson, H.D. Nothdurft, B. Beck, and E. Schwartz Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study BMJ 327 2003 1078
4. L.H. Chen, M.E. Wilson, and P. Schlagenhauf Controversies and misconceptions in malaria chemoprophylaxis for travelers JAMA 297 2007 2251 2263 (Pubitemid 47010883)
5. M.M. van Riemsdijk, M.C. Sturkenboom, J.M. Ditters, J.H. Tulen, R.J. Ligthelm, and D. Overbosch Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine Br J Clin Pharmacol 57 2004 506 512 (Pubitemid 38519657)
6. E. Schwartz, I. Potasman, M. Rotenberg, S. Almog, and S. Sadetzki Serious adverse events of mefloquine in relation to blood level and gender Am J Trop Med Hyg 65 2001 189 192 (Pubitemid 32847809)
7. M.M. van Riemsdijk, J.M. Ditters, M.C. Sturkenboom, J.H. Tulen, R.J. Ligthelm, and D. Overbosch Neuropsychiatric events during prophylactic use of mefloquine before travelling Eur J Clin Pharmacol 58 2002 441 445
8. N. Corominas, J. Gascon, T. Mejias, F. Caparros, L. Quinto, and C. Codina Adverse effects associated with antimalarial chemoprophylaxis Med Clin (Barc) 108 1997 772 775 (Pubitemid 27231672)
9. D. Huzly, C. Schonfeld, W. Beuerle, and U. Bienzle Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions J Travel Med 3 1996 148 155 (Pubitemid 126679282)
10. L. Ollivier, K. Tifratene, R. Josse, A. Keundjian, and J.P. Boutin The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study Ann Trop Med Parasitol 98 2004 639 641 (Pubitemid 39215519)
11. M.A. Phillips, and R.B. Kass User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis J Travel Med 3 1996 40 45 (Pubitemid 126673659)
12. The prescribing references for general practicioners 2007 October 2007 MIMS
13. D.H. Lawson, V. Sherman, and J. Hollowell The general practice research database. Scientific and Ethical Advisory group QJM 91 1998 445 452 (Pubitemid 28286844)
14. H. Jick A database worth saving Lancet 350 1997 1045 1046 (Pubitemid 27437853)
15. L. Wood, and C. Martinez The general practice research database: role in pharmacovigilance Drug Saf 27 2004 871 881 (Pubitemid 39331685)
16. H. Jick, S.S. Jick, and L.E. Derby Validation of information recorded on general practitioner based computerised data resource in the United Kingdom BMJ 302 1991 766 768
17. C. Kuehner Gender differences in unipolar depression: an update of epidemiological findings and possible explanations Acta Psychiatr Scand 108 2003 163 174 (Pubitemid 36963066)
18. P. Schlagenhauf, R. Johnson, E. Schwartz, H.D. Nothdurft, and R. Steffen Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study J Travel Med 16 2009 42 45
19. M.M. van Riemsdijk, M.C. Sturkenboom, J.M. Ditters, R.J. Ligthelm, D. Overbosch, and B.H. Stricker Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events Clin Pharmacol Ther 72 2002 294 301
20. J.L. Bem, L. Kerr, and D. Stuerchler Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions J Trop Med Hyg 95 1992 167 179
21. S. Watt-Smith, K. Mehta, and C. Scully Mefloquine-induced trigeminal sensory neuropathy Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 2001 163 165 (Pubitemid 33601718)
22. A.C. Chester, and P. Sandroni Case report: peripheral polyneuropathy and mefloquine prophylaxis Am J Trop Med Hyg 85 2011 1008 1009